Article Details

FDA Approves Phase 1 Trial of CNTY-101 for People with Systemic Lupus Erythematosus

Retrieved on: 2023-12-19 19:53:34

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Phase 1 Trial of CNTY-101 for People with Systemic Lupus Erythematosus. View article details on hiswai:

Excerpt

... (immune system cells involved in the production of autoantibodies and lupus disease activity). CNTY-101 is made of modified immune NK cells (or ...

Article found on: www.lupus.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo